Category: Latest News
-
Oklo Stock Gains After Clearing Key Regulatory Hurdle for Aurora Project
Shares of Oklo Inc. (NYSE:OKLO) rose 2.5% after the company announced it has successfully completed the U.S. Nuclear Regulatory Commission’s (NRC) pre-application readiness assessment for its first commercial Aurora powerhouse. The NRC found no major deficiencies in Phase 1 of Oklo’s combined license application (COLA) for the proposed facility at Idaho National Laboratory, signaling that…
-
Bitmine Stock Rises as Ethereum Holdings Surpass $1 Billion
Shares of Bitmine Immersion Technologies Inc. (AMEX:BMNR) climbed 7.5% after the company disclosed that its Ethereum (ETH) holdings have exceeded $1 billion in value. As of July 17 at 3:45 a.m. ET, Bitmine reported holding 300,657 ETH at a market price of $3,461.89 per token. The milestone comes just a week after the company completed…
-
Webull Shares Gain on Plans to Relaunch Crypto Trading in U.S.
Webull Corporation (NASDAQ:BULL) shares rose 4% on Wednesday after the company announced plans to resume cryptocurrency trading in the United States during the third quarter as part of a broader restructuring. The online brokerage said it will reintegrate Webull Pay LLC into the core Webull group, consolidating its crypto operations under one structure. The move…
-
U.S. Stocks Edge Higher on Strong Retail Sales; Netflix Earnings in Focus
U.S. equities nudged higher on Thursday, supported by upbeat retail sales data and a wave of corporate earnings. As of 9:35 a.m. ET, the Dow Jones Industrial Average was up 100 points, or 0.2%, while the S&P 500 rose 4 points (0.1%) and the NASDAQ Composite gained 20 points (0.1%). Netflix Earnings Ahead Investor sentiment…
-
Rocket Pharmaceuticals Shares Jump After FDA Grants Accelerated Review Status to Gene Therapy
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) surged 15% after receiving a key regulatory boost from the U.S. Food and Drug Administration (FDA), which granted its investigational gene therapy RP-A601 the Regenerative Medicine Advanced Therapy (RMAT) designation. The therapy is being developed to treat PKP2-arrhythmogenic cardiomyopathy (PKP2-ACM), a rare and potentially fatal inherited heart condition associated with arrhythmias…
-
LQR House Shares Slide After Lawsuit Seeks Asset Freeze and Court-Appointed Receiver
Shares of LQR House Inc. (NASDAQ:LQR) sank 24% on Thursday following news that the company has been named in a lawsuit requesting an asset freeze and court oversight of its operations. Filed by Kingbird Ventures, LLC in Nevada’s Eighth Judicial District Court on July 11, the suit targets LQR House and its full board of…
-
Disco Posts Solid Q1 Earnings, Sees Q2 Shipment Slowdown Amid Front-Loaded Demand
Disco Corporation (USOTC:DSCSY) reported robust first-quarter results, with revenue climbing to ¥89.9 billion—an 8.6% year-over-year increase—and operating profit reaching ¥34.4 billion, up 3.3%. The figures follow a recent guidance revision announced on July 9. The company’s operating profit came in roughly ¥10 billion higher than internal forecasts, excluding currency effects, with an additional ¥4 billion…
-
Volcon Shares Surge Over 300% Following $500M Bitcoin-Focused Private Placement
Volcon Inc. (NASDAQ:VLCN) shares soared more than 300% after the electric off-road vehicle maker announced a dramatic shift in strategy, fueled by a $500 million private placement aimed at building a substantial Bitcoin treasury. The Austin-based company disclosed that it has entered into securities purchase agreements with institutional and accredited investors to sell roughly 50.1…
-
Digi Power X Shares Jump After Securing Supermicro Systems for AI Infrastructure Expansion
Digi Power X Inc. (NASDAQ:DGXX) saw its stock climb 11% after announcing a major equipment purchase aimed at boosting its AI capabilities. The company has placed a purchase order with Super Micro Computer Inc. (NASDAQ:SMCI) for systems powered by NVIDIA’s (NASDAQ:NVDA) B200 GPUs, which will support its NeoCloud AI platform. These Supermicro units will be…
-
Cintas Tops Q4 Estimates as Revenue and Margins Improve
Cintas Corporation (NASDAQ:CTAS) reported stronger-than-expected fourth-quarter results on Thursday, driven by solid sales momentum and improved profitability. The company also released guidance for its upcoming fiscal year. For the quarter ending May 31, Cintas earned $1.09 per share, exceeding analyst expectations by $0.02. Revenue climbed 8% year-over-year to $2.67 billion, surpassing Wall Street estimates. Shares…